期刊
PHARMACOLOGICAL RESEARCH
卷 45, 期 2, 页码 119-124出版社
ACADEMIC PRESS LTD ELSEVIER SCIENCE LTD
DOI: 10.1006/phrs.2001.0913
关键词
melanotan-II (MTII); SCH 23982; NCQ-298
Previous studies have shown that melanocortin peptides have facilitatory effects on dopaminergic neurotransmission. In the present study we tested the hypothesis that chronic exposure to melanocortin receptor agonists causes a prolonged release of dopamine resulting in changes in the expression of dopamine receptor subtypes. Using an autoradiographic approach we found that a 2 week intracerebroventricular infusion of the melanocortin receptor agonist melanotan-II induced changes in dopamine D-1-like and D-2-like receptor binding in several regions of the rat brain. D-1-like receptor binding was increased in the nucleus accumbens and the caudate putamen, but reduced in the substantia nigra (reticular part), whereas D-2-like receptor binding was reduced in the caudate putamen, but increased in the periaqueductal grey, substantia nigra (compact part) and the ventral tegmental area. These data suggest that chronic infusion of a melanocortin receptor agonist alters the activity of dopaminergic neurons in the ventral tegmental area and substantia nigra, and support the hypothesis that melanocortin peptides may regulate the activity of central dopamine neurons. (C) 2002 Elsevier Science Ltd.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据